SlideShare a Scribd company logo
  • Upload
  • Home
  • Explore
  • Login
  • Signup
SlideShare a Scribd company logo
  • Home
  • Explore
  • Upload
  • Login
  • Signup

We've updated our privacy policy. Click here to review the details. Tap here to review the details.

×
×
×
×
×
×
Rob Gallo

Rob Gallo

1 Follower
2 SlideShares 0 Clipboards 1 Follower 0 Followings
  • Unblock User Block User
2 SlideShares 0 Clipboards 1 Follower 0 Followings

Personal Information
Organization / Workplace
Zürich Area, Switzerland Switzerland
Occupation
Corporate communication & issues management professional. The views expressed here are my own.
Website
robgallo.org
About
Rob Gallo is a seasoned corporate communications director and issues management professional with 15+years combined experience in both consumer and corporate communications. Since 2012, Rob has served as the Head of Corporate Communications for Takeda Pharmaceuticals, overseeing their European & Canadian territories. Rob’s passion for driving interpersonal connections has lead him to develop a wealth of corporate initiatives targeted towards inspiring empathy across colleagues and external audiences. Rob believes that his profession is uniquely placed to earn insights that enable organisations to connect to their audience in a personal and meaningful way. His passion for digital innovati...
Contact Details
Tags
health health issues ibd eucan healthcare presentations communication presenting speaking slideshows business public speaking pecha kucha
See more
Users following Rob Gallo
Megan Davies Profile
Megan Davies
1 following
  • About
  • Support
  • Terms
  • Privacy
  • Copyright
  • Cookie Preferences
  • Do not sell or share my personal information
English
Current Language: English
Español
Português
Français
Deutsch

© 2023 SlideShare from Scribd

We've updated our privacy policy.

We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.

You can read the details below. By accepting, you agree to the updated privacy policy.

Thank you!

View updated privacy policy
We've encountered a problem, please try again.